Acute Delirium in the Setting of Primary Hypothyroidism: The Role of Thyroid Hormone Replacement Therapy

Thyroid ◽  
2005 ◽  
Vol 15 (9) ◽  
pp. 1099-1101 ◽  
Author(s):  
Samer El-Kaissi ◽  
Mark A. Kotowicz ◽  
Michael Berk ◽  
Jack R. Wall
Keyword(s):  
Hormone Replacement Therapy ◽  
Thyroid Hormone ◽  
Replacement Therapy ◽  
Hormone Replacement ◽  
Primary Hypothyroidism ◽  
Thyroid Hormone Replacement ◽  
Thyroid Hormone Replacement Therapy

Proteinuria in Severe Hypothyroidism: A Prospective Study

2020 ◽  
Author(s):  
Vijay Singh Gondil ◽  
Aarthi Chandrasekaran ◽  
Ashu Rastogi ◽  
Ashok Kumar Yadav ◽  
Ashwani Sood ◽  
...  
Keyword(s):  
Hormone Replacement Therapy ◽  
Thyroid Hormone ◽  
Replacement Therapy ◽  
Hormone Replacement ◽  
Primary Hypothyroidism ◽  
Urine Protein ◽  
Thyroid Hormone Replacement ◽  
Urine Protein Excretion ◽  
Protein Excretion ◽  
Thyroid Hormone Replacement Therapy

Abstract Context Hypothyroidism is associated with reversible decline in kidney function as measured by estimated glomerular filtration rate (eGFR). eGFR and proteinuria are the most important markers for clinical assessment of kidney function. Though hypothyroidism is associated with proteinuria in cross-sectional data, the impact of treatment on proteinuria is unknown. Objective This study explores the effect of thyroid hormone replacement therapy on eGFR and 24-hour urine protein excretion in patients with severe primary hypothyroidism. Design and Participants This study was a prospective, observational cohort study in adults with severe primary hypothyroidism (serum thyrotropin [TSH] > 50 µIU/mL). Individuals with preexisting or past kidney disease, kidney or urinary tract abnormalities, calculi or surgery, diabetes mellitus, or hypertension were excluded. The participants received thyroid hormone replacement therapy. Thyroid functions, eGFR, 24-hour urine protein excretion, and biochemical parameters were measured at baseline and 3 months. Setting This study took place at a single center, a tertiary care referral and teaching hospital. Results Of 44 enrolled participants, 43 completed 3 months of follow-up. At 3 months, serum TSH levels decreased and thyroxine levels increased (P < .001 for both). Significant increases in eGFR (mean difference, 18.25 ± 19.49 mL/min/1.73 m2; 95% CI, 12.25 to 24.25, P < .001) and declines in 24-hour urine protein excretion (mean difference, –68.39 ± 125.89 mg/day; 95% CI, –107.14 to –29.65, P = .001) were observed. Serum cholesterol and low-density lipoprotein levels also significantly decreased (P < .001). Conclusions Thyroid hormone replacement therapy in patients with severe primary hypothyroidism improves eGFR and decreases 24-hour urine protein excretion, thereby suggesting reversible alterations.

Sign in / Sign up

Export Citation Format

Share Document